A Study to Evaluate the Safety and Efficacy of Rencofilstat in Adult Subjects With NASH F3

Clinical trial NCT05461105 · COMPLETED

Trial details

NCT number: NCT05461105
Sponsor: Hepion Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

NASH With Fibrosis

Start date: 2022-03-15
Primary completion: 2023-04-15
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.